Ad-hoc | 6 November 2006 10:39

Price range for WILEX shares set at EUR 13.80 to EUR 15.80

Ad hoc announcement transmitted by DGAP – a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. —————————————————————————— Ad-hoc-Announcement according to § 15 WpHG Price range for WILEX shares set at EUR 13.80 to EUR 15.80 Planned issue volume between EUR 63.5 million and EUR 72.7 million (including greenshoe) / Subscription period from November 7th to 9th, 2006 Munich, November 6, 2006 – The biopharmaceutical company WILEX AG today set the price range for the shares to be made available for subscription through a bookbuilding procedure at EUR 13.80 to EUR 15.80 per share. The offer consists of up to 4.6 million shares including an over-allotment option (‘greenshoe”) of up to 600,000 shares. Up to 4,000,000 shares are from an increase in capital approved at the ordinary shareholders’ meeting on September 11, 2006. With the approval of the supervisory board the executive management board is able to resolve to issue up to 600,000 shares from a capital increase of the authorized capital. The planned issue volume is between up to EUR 63.5 million to up to EUR 72.7 million (including greenshoe). Investors interested in acquiring the shares will have an opportunity to subscribe to WILEX AG shares during a time period that will start on November 7, 2006 and is expected to end on November 9, 2006. The subscription period is expected to end on November 9, 2006, at 12 noon CET for retail investors and at 3 pm CET on the same day for institutional investors. The admission of the shares of WILEX AG to the Official Market Segment (Amtlicher Markt) as well as to the sub-segment of the Official Market Segment with additional post-admission obligations (Prime Standard) at the Frankfurt Stock Exchange was filed for on October 23, 2006. ISIN DE0006614720; Securities Identification Number (WKN) 661472. Contact Juliane Giese Manager Public Relations WILEX AG Grillparzerstr. 16 81675 Munich Germany Tel.: +49 (0)89-41 31 38-29 Fax: +49 (0)89-41 31 38-99 Email: juliane.giese@wilex.com Please note: This document is not a prospectus and does not constitute an offer to sell or the solicitation of an offer to purchase the Shares or other securities of Wilex AG. Investors should not subscribe for any shares referred to in this document except on the basis of the information contained in the prospectus relating to the Shares. A free copy of the prospectus is available to investors at the Company, (fax number +49 89 41 31 38 99), the Sole Lead Manager and Sole Book Runner WestLB AG, Düsseldorf (fax number +49 211 826 8146) and the Co Lead Manager Sal. Oppenheim jr. & Cie. Kommanditgesellschaft auf Aktien, Cologne (fax number +49 69 71 34 51 69). This document is not an offer to buy securities in the United States of America. Securities may only be sold or offered for purchase in the United States of America with prior registration subject to the provisions of the US Securities Act 1933 in the currently-valid version, or in the absence of prior registration, only on the basis of an exception. Shares in WILEX AG are not and will not be registered pursuant to the provisions of the US Securities Act 1933 in the currently-valid version, and will neither be sold nor offered for purchase in the United States of America. The information contained in this document is not intended to be passed on into the USA or within the USA. This document is directed at and/or for distribution in the U. K. only to (i) persons who have professional experience in matters relating to investments falling within article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the ‘Order”) or (ii) high net worth entities falling within article 49(2)(a) to (d) of the Order (all such persons being together referred to as ‘relevant persons”). This document is directed only at relevant persons. Any person who is not a relevant person should not act or rely on this document or any of its contents. Any investment or investment activity to which this document relates is available only to relevant persons and will be engaged in only with relevant persons. Back to press releases (c)DGAP 06.11.2006 ————————————————————————— Language: English Issuer: WILEX AG Grillparzerstr. 16 81675 München Deutschland Phone: +49 (0)89 41 31 38 – 0 Fax: +49 (0)89 41 31 38 – 99 E-mail: info@wilex.com WWW: www.wilex.de ISIN: DE0006614720 WKN: 661472 Indices: Listed: Amtlicher Markt in Frankfurt (Prime Standard) Notierung vorgesehen / designated to be listed End of News DGAP News-Service —————————————————————————